ABBV vs TECH: Options Risk Comparison

AbbVie Inc. and BIO-TECHNE Corp compared side by side — risk score, IV Rank, edge and earnings. Updated every 30 minutes.

Metric	ABBV	TECH
Risk Score	100	32
Risk Band	HIGH	LOW
IV Rank	71.6	34.4
IV %	30.6%	43.1%
Edge Score	-28	+2
Price Δ	-1.5%	+0.3%
Next Earnings	2026-10-29	2026-11-09
Sector	Health Care	Health Care

Which has higher options risk?

AbbVie Inc. (ABBV) currently carries the higher options risk score (100 vs 32 for TECH) — meaning more active catalysts that can drive an overnight move. For selling option premium, BIO-TECHNE Corp (TECH) has the better edge score (+2) — a stronger blend of high IV Rank and low risk.

Risk score (0–100) reflects active catalysts — earnings, legal, SEC filings and news. Edge score = IV Rank − risk score; higher is better for selling premium.

Run a full scan on each — free

Scan ABBV → Scan TECH →

Full risk pages

ABBV risk, IV & earnings TECH risk, IV & earnings

More Health Care comparisons

ABBV vs ABT ABBV vs A ABBV vs ALGN ABBV vs AMGN ABBV vs BAX ABBV vs BDX ABBV vs BIIB ABBV vs BSX

TickerRisk provides risk scoring for informational purposes only. Not financial advice. Options trading involves substantial risk of loss. Full disclaimer